Company / Operating Cash Flow
Prime Medicine, Inc. Operating Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$122.9M
FY2024
5-year range
-$165.4M / -$5.5M
FY2020-FY2024
Trend
+25.7%
vs FY2023
Sector context
#140 of 215
Health Care
What the data says
At -$123M, Prime Medicine, Inc.'s operating cash flow ranks #140 of 215 in the Health Care sector. Operating Cash Flow returned to growth in FY2024 after 3 years of decline, reaching -$123M.
Based on SEC 10-K filings.
-$123M in FY2024.
Improved from -$132M to -$123M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 215 in Health CareTop 65% of 215This company -$122.9M Sector average $661.2M
▼
-118.6% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow increased 25.7% year-over-year.
- Ranks #140 out of 215 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$122.9M | +25.7% |
| FY2023 | -$165.4M | -25.5% |
| FY2022 | -$131.8M | -286.8% |
| FY2021 | -$34.1M | -514.8% |
| FY2020 | -$5.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026